Literature DB >> 16732001

Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population.

Peter T Donnan1, Louise Donnelly, John P New, Andrew D Morris.   

Abstract

OBJECTIVE: To derive and validate an absolute risk algorithm for major coronary heart disease (CHD) events in the U.K. population with type 2 diabetes. RESEARCH DESIGN AND METHODS: A population cohort with type 2 diabetes was constructed in Tayside, Scotland, U.K., and longitudinally followed-up to June 2004. Participants were all people with type 2 diabetes registered with general practices and the Diabetes Audit and Research in Tayside, Scotland, database (97% sensitive) with no previous CHD event and with complete measurements (n = 4,569). The main outcome measure was risk of CHD defined as fatal or nonfatal myocardial infarction or CHD death, derived from the Weibull accelerated failure-time model. Validation of the algorithm was performed on an independent dataset from Salford, England, U.K.
RESULTS: There were a total of 243 subjects (5.3%) with a fatal or nonfatal myocardial infarction or CHD death over the follow-up period from 1 January 1995 to 30 June 2004 (maximum follow-up 9.5 years). The final Weibull model included the significant predictors of age at diagnosis, duration of diabetes, HbA(1c), smoking (current, past, never), sex, systolic blood pressure, treated hypertension, total cholesterol, and height. Assessment of discrimination and calibration in the Salford validation dataset demonstrated a good fit (c = 0.71 [95% CI 0.63-0.79]).
CONCLUSIONS: This study provides the first validated, population-derived model for prediction of absolute risk of CHD in people with type 2 diabetes. It provides a useful additional decision aid for the clinician treating type 2 diabetes by indicating appropriate early action to decrease the risk of adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732001     DOI: 10.2337/dc05-1911

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  22 in total

1.  Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.

Authors:  P McEwan; H Bennett; T Ward; K Bergenheim
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

Review 2.  Cardiovascular risk.

Authors:  Rupert A Payne
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

Review 3.  Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its Complications.

Authors:  Simon Lebech Cichosz; Mette Dencker Johansen; Ole Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2015-10-14

4.  Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism.

Authors:  Chang Ho Ahn; Se Hee Min; Dong-Hwa Lee; Tae Jung Oh; Kyoung Min Kim; Jae Hoon Moon; Sung Hee Choi; Kyong Soo Park; Hak Chul Jang; Joon Ha; Arthur S Sherman; Soo Lim
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

5.  The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.

Authors:  A P Kengne; A Patel; S Colagiuri; S Heller; P Hamet; M Marre; C Y Pan; S Zoungas; D E Grobbee; B Neal; J Chalmers; M Woodward
Journal:  Diabetologia       Date:  2010-02-17       Impact factor: 10.122

6.  Cardiovascular Disease Incidence and Risk Factor Patterns among Omanis with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Abdul Hakeem Al Rawahi; Patricia Lee; Zaher A M Al Anqoudi; Ahmed Al Busaidi; Muna Al Rabaani; Faisal Al Mahrouqi; Ahmed M Al Busaidi
Journal:  Oman Med J       Date:  2017-03

7.  Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study.

Authors:  C Raina Elley; Elizabeth Robinson; Tim Kenealy; Dale Bramley; Paul L Drury
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 17.152

8.  Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe.

Authors:  J Francisco Cano; Jose M Baena-Diez; Josep Franch; Joan Vila; Susana Tello; Joan Sala; Roberto Elosua; Jaume Marrugat
Journal:  Diabetes Care       Date:  2010-06-08       Impact factor: 19.112

9.  Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study.

Authors:  Shou-En Lu; Gloria L Beckles; Jesse C Crosson; Dorian Bilik; Andrew J Karter; Robert B Gerzoff; Yong Lin; Sonja V Ross; Laura N McEwen; Beth E Waitzfelder; David Marrero; Norman Lasser; Arleen F Brown
Journal:  BMC Endocr Disord       Date:  2012-07-09       Impact factor: 2.763

Review 10.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.